Myeloma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
For patients with a blood or bone marrow condition:
- People who are older than 18 years
- Both men and women are eligible
- People who have been diagnosed with MGUS, smouldering myeloma, or multiple myeloma, confirmed by a tissue or bone marrow test, according to recognised medical guidelines
- People who are willing and able to sign a consent form agreeing to take part
For healthy volunteers:
- People who are older than 60 years
- People who have been diagnosed with osteoarthritis (a condition where joints wear down over time)
- People who are already scheduled to have joint replacement or joint repair surgery for their osteoarthritis
- People who are willing and able to sign a consent form agreeing to take part
Who may not be able to join:
For patients:
- People who currently have an active infection
- People who have an autoimmune disease (a condition where the immune system attacks the body)
- Women who are able to become pregnant and cannot confirm they are not currently pregnant
- People who have taken high-dose steroid medications in the past 7 days, as this may affect results
For healthy volunteers:
- People who have had previous surgery on the affected joint, or who have severe joint deformity
- People whose joint condition is linked to a recent injury, bone tissue loss, or a past or current joint infection
- People who have a metabolic disorder (a condition affecting how the body processes energy or substances)
- People who have ever been diagnosed with cancer, either in the past or currently
- People who have an autoimmune disease, such as rheumatoid arthritis
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Bone marrow and peripheral blood immunophenotypic characterization; Genomic and transcriptomic profiling of plasma cell; Single-cell and spatial transcriptomic analyses
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.